Beam stock forecast.

Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.

Beam stock forecast. Things To Know About Beam stock forecast.

Find real-time BEEM - Beam Global stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.28: Annual revenue (last year) $22.0M: Annual profit (last ...Oct 15, 2020 · The Beam Therapeutics stock forecast is 57.069107374265 USD for 2024 November 25, Monday; and 177.367 USD for 2028 November 25, Saturday with technical analysis. Beam Therapeutics (BEAM) stock price prediction is 57.069107374265 USD. Based on those assumptions, my modeling says Aeva could do about $10 in earnings per share by 2030. A simple 20X multiple on that implies a long-term potential price target here of $200. The AEVA ...Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...

BEAM stock, belonging to Beam Therapeutics Inc, has shown promising performance on August 29, 2023, according to data from CNN Money. The 15 analysts offering 12-month price forecasts for BEAM stock have a median target of $56.00, with a high estimate of $105.00 and a low estimate of $32.00.Beam Global analyst ratings, historical stock prices, earnings estimates & actuals. BEEM updated stock price target summary.

Find real-time NOK - Nokia Oyj stock quotes, company profile, news and forecasts from CNN Business.Nov 15, 2023 · Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year).

Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFind the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.

Find real-time SMG - Scotts Miracle-Gro Co stock quotes, company profile, news and forecasts from CNN Business.

Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...Meta Platforms Inc. () Stock Market info Recommendations: Buy or sell Meta Platforms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Meta Platforms share forecasts, stock quote and buy / sell signals below.According to present data Meta Platforms's META shares and potentially its market environment have …As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.Steel beams are a crucial component in construction projects, providing structural support for buildings, bridges, and other infrastructure. However, not all steel beams are created equal.Stock Splits: Mergers & Acquisitions: Business Services/Equipment M&A Construction M&A General Contractors & Builders M&A Consumer Goods M&A Sporting Goods & Activities M&A Office Supplies M&A Food & Beverage M&A Beverages & Wineries M&A Cigarettes & Tobacco M&A Marijuana Stocks M&A Apparel Stores M&A Department Stores M&A …

Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.Oct 28, 2023 · Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts. Find real-time ROKU - Roku Inc stock quotes, company profile, news and forecasts from CNN Business.Forecasted world HRC benchmark steel price for 2023. After demand for steel dropped during the arrival of the COVID-19 pandemic in 2019, steel prices also took a hit. However, in 2021, hot-rolled ...Get The Latest CRWD Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,594.63 (+0.59%)This morning Beam, an insurtech startup that provides dental coverage to corporate employees, announced that it has closed an $80 million Series E. Mercato-affiliated Traverse led the investment, with Nationwide insurance joining the deal. ...Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any …

The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ...

Beam Global has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on BEEM's earnings history.Key Points. Cathie Wood is an icon in the world of disruptive tech. Her firm ARK Invest holds positions in Beam Therapeutics, COMPASS Pathways, and 908 Devices. Wall Street analysts have ...“This call aims to develop an USPL that is ruggedized enough to begin testing in relevant Army environments,” it continued. The Army also began testing a prototype laser weapon for close-range air defense in May, the Defense Post reported.The high-energy laser will be able to locate, lock on, track and destroy aerial threats in just seconds.On average, analysts forecast that MSFT's EPS will be $11.13 for 2024, with the lowest EPS forecast at $10.83, and the highest EPS forecast at $11.55. On average, analysts forecast that MSFT's EPS will be $12.71 for 2025, with the lowest EPS forecast at $12.05, and the highest EPS forecast at $13.38.Infibeam Avenue Share Price: Find the latest news on Infibeam Avenue Stock Price. Get all the information on Infibeam Avenue with historic price charts for ...Find real-time HAL - Halliburton Co stock quotes, company profile, news and forecasts from CNN Business.Beam Therapeutics (BEAM) Stock Forecast & Price Target $29.47 +1.52 (+5.44%) (As of 11/22/2023 ET) Compare Today's Range $28.24 $29.84 50-Day Range …Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.

ETSY Stock 12 Months Forecast. $74.39. (0.59% Upside) Based on 23 Wall Street analysts offering 12 month price targets for Etsy in the last 3 months. The average price target is $74.39 with a high forecast of $125.00 and a low forecast of $50.00. The average price target represents a 0.59% change from the last price of $73.95.

Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.Electronic Technology. Industry. Aerospace & Defense. No executives to display. Corporate headquarters. --, --. Find real-time ACHR - Archer Aviation Inc stock quotes, company profile, news and ...Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.SmartAssetPaid Partner. Find real-time FSR - Fisker Inc stock quotes, company profile, news and forecasts from CNN Business.Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsIn today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Oct 20, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $53.64 with a high price target of $105.00 and a low price target of $20.00. 0.99%. €17.62M. IBAB | Complete Ion Beam Applications S.A. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

A.1 https://beststocks.com/target/aaon-stock-forecasthttps://beststocks.com/target/abt-stock-forecasthttps://beststocks.com/target/abbv-stock-forecasthttps ...Infibeam Avenue Share Price: Find the latest news on Infibeam Avenue Stock Price. Get all the information on Infibeam Avenue with historic price charts for ...As for the stock performance of Beam Therapeutics, on October 2nd, it opened at $24.05. Over the past 50 days, the stock has exhibited a moving average price of $25.47, while its 200-day moving average stands at $29.78. It is worth noting that BEAM’s fifty-two week low is reported to be $22.52, with a high point of $54.30 during the same period.Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $102.85M. -16.4%. Market Cap / Employee. The market cap of a ...Instagram:https://instagram. social trading platformst206 honus wagner baseball cardcan you purchase ripple on coinbasehow much is 1921 morgan silver dollar worth BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global, the second EV charging ... divo holdingsbest airline stocks Find the latest Ion Beam Applications SA (IBAB.BR) stock quote, history, news and other vital information to help you with your stock trading and investing. how to trade xsp options The 6 analysts offering 12-month price forecasts for Beam Global have a median target of 25.00, with a high estimate of 40.00 and a low estimate of 12.00. The median estimate represents a +355.37% ...A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.